Medical management of glaucoma in the 21st century from a Canadian perspective
P Harasymowycz, C Birt, P Gooi… - Journal of …, 2016 - Wiley Online Library
Glaucoma is a medical term describing a group of progressive optic neuropathies
characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and …
characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and …
[图书][B] Clinical ocular pharmacology
JD Bartlett, SD Jaanus - 2007 - books.google.com
Written by experts in the field, this comprehensive resource offers valuable information on
the practical uses of drugs in primary eye care. Discussions of the pharmacology of ocular …
the practical uses of drugs in primary eye care. Discussions of the pharmacology of ocular …
[HTML][HTML] In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society …
C Baudouin, A Denoyer, N Desbenoit… - Transactions of the …, 2012 - ncbi.nlm.nih.gov
Purpose: Long-term antiglaucomatous drug administration may cause irritation, dry eye,
allergy, subconjunctival fibrosis, or increased risk of glaucoma surgery failure, potentially …
allergy, subconjunctival fibrosis, or increased risk of glaucoma surgery failure, potentially …
[图书][B] Glaukom: Grundlagen Differentialdiagnose Therapie
MB Shields, GK Krieglstein - 2013 - books.google.com
Es ist das Verdienst von Professor Günter K. Krieglstein, das weltweit verwendete
Standardwerk über Glaukome von M. Bruce Shields ins Deutsche übersetzt und im Hinblick …
Standardwerk über Glaukome von M. Bruce Shields ins Deutsche übersetzt und im Hinblick …
Нежелательные явления гипотензивной терапии глаукомы
ЕА Егоров, АЕ Егоров, ТО Елисеева… - РМЖ. Клиническая …, 2011 - cyberleninka.ru
Клиническая офтальмология роговицы, жжение и зуд в глазах, гиперемия кожи век,
кратковременное нарушение остроты зрения; блефарит, конъюнктивит, кератит, при …
кратковременное нарушение остроты зрения; блефарит, конъюнктивит, кератит, при …
Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist
A Peeters, J Schouten, CAB Webers, MH Prins… - Eye, 2008 - nature.com
Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle
glaucoma by the ophthalmologist | Eye Skip to main content Thank you for visiting nature.com …
glaucoma by the ophthalmologist | Eye Skip to main content Thank you for visiting nature.com …
Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients
MF Cordeiro, I Goldberg, R Schiffman… - Clinical …, 2015 - Taylor & Francis
Purpose To evaluate, using subgroup analysis, the effect of treatment status on the
intraocular pressure (IOP)-lowering efficacy of a preservative-free formulation of fixed …
intraocular pressure (IOP)-lowering efficacy of a preservative-free formulation of fixed …
[HTML][HTML] A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG
C Hartleben-Matkin, D Prada… - International Journal of …, 2014 - ncbi.nlm.nih.gov
AIM To evaluate the long-term response to the fixed combination of dorzolamide/timolol in
patients with primary open angle glaucoma (POAG) and the addition of other intraocular …
patients with primary open angle glaucoma (POAG) and the addition of other intraocular …
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
J Shen, M Bejanian - Clinical Ophthalmology, 2016 - Taylor & Francis
Purpose Many patients with glaucoma require combination therapies to achieve target
intraocular pressure (IOP) and preserve visual function. Ocular hypotensives often contain a …
intraocular pressure (IOP) and preserve visual function. Ocular hypotensives often contain a …
[HTML][HTML] Long-term follow-up of patients receiving intraocular pressure-lowering medications as cataract surgery candidates: a case-control study
G Bontzos, M Agiorgiotakis… - Journal of current …, 2017 - ncbi.nlm.nih.gov
Aim In this study, we reviewed demographics and biometric characteristics among patients
receiving chronic β-blockers and prostaglandins (PGs) for primary open-angle glaucoma …
receiving chronic β-blockers and prostaglandins (PGs) for primary open-angle glaucoma …